US 12286405
Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase
granted A61PA61P25/00
Quick answer
US patent 12286405 (Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Apr 29 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 24 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P25/00